# FDA Inspection 1114619 - ImpactLife - December 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/impactlife/7eeb5a64-ec1a-4536-8608-7a690d7bb142
Source feed: FDA_Inspections

> FDA Inspection 1114619 for ImpactLife on December 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1114619
- Company Name: ImpactLife
- Inspection Date: 2019-12-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1228231 - 2024-01-30](https://www.keypedia.com/records/fda_inspections/impactlife/a96b7f76-0002-4aa9-9837-1beca8868e65)
- [FDA Inspection 1030104 - 2017-10-05](https://www.keypedia.com/records/fda_inspections/impactlife/b5388481-e88f-4eb9-8925-887b743e06ce)
- [FDA Inspection 947867 - 2015-10-08](https://www.keypedia.com/records/fda_inspections/impactlife/119792fd-ff81-4653-9a6c-3b1f1bac5fa0)
- [FDA Inspection 853919 - 2013-11-04](https://www.keypedia.com/records/fda_inspections/impactlife/99e4cd91-9eda-404e-8886-f7d0f3397e84)
- [FDA Inspection 776355 - 2012-04-02](https://www.keypedia.com/records/fda_inspections/impactlife/cdc19e78-982a-449d-a912-8fa1b420b913)

Company: https://www.keypedia.com/companies/impactlife/44f31701-2e9e-4739-b335-b06b57286dc5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d